News
06-07-2010, 11:50 PM
Chronix Biomedical today reported new data further demonstrating that its DNA blood tests have the potential to accurately detect early stage breast and prostate cancers. Chronix's proprietary technology identifies disease-specific genetic fingerprints based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells.
More... (http://www.news-medical.net/news/20100608/Chronix-DNA-blood-tests-detect-prostate-breast-cancer-with-9225-sensitivity-and-10025-specificity.aspx)
More... (http://www.news-medical.net/news/20100608/Chronix-DNA-blood-tests-detect-prostate-breast-cancer-with-9225-sensitivity-and-10025-specificity.aspx)